EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors

Sameer Farouk Sait, Kwan Ho Tang, Steven P Angus iD, Rebecca Brown iD, Daochun Sun, Xuanhua Xie iD, Charlene Iltis iD, Michelle Lien, Nicholas D Socci, Tejus A Bale, Christopher Davis, Shelley A H Dixon iD und 4 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2407745121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Sameer Farouk Sait und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology & Genetics Program, Sloan Kettering Institute, New York, NY 10065. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Hydroxychloroquine, Drug Resistance, Neoplasm, Xenograft Model Antitumor Assays. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP), HHS | National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and the primary cause of mortality in patients with neurofibromatosis type 1 (NF1). These malignancies develop within preexisting benign lesions called plexiform neurofibromas (PNs). PNs are solely driven by biallelic NF1 loss eliciting RAS pathway activation, and they respond favorably to MEK inhibitor therapy. MPNSTs harbor additional mutations and respond poorly to MEK inhibition. Our analysis of genetically engineered and orthotopic patient-derived xenograft MPNST models indicates that MEK inhibition has poor antitumor efficacy. By contrast, upstream inhibition of RAS through the protein-tyrosine phosphatase SHP2 reduced downstream signaling and suppressed NF1 MPNST growth, although resistance eventually emerged. To investigate possible mechanisms of acquired resistance, kinomic analyses of resistant tumors were performed, and data analysis identified enrichment of activated autophagy pathway protein kinases. Combining SHP2 inhibition with hydroxychloroquine (HQ) resulted in durable responses in NF1 MPNSTs in both genetic and orthotopic xenograft mouse models. Our studies could be rapidly translated into a clinical trial to evaluate SHP2 inhibition in conjunction with HQ as a unique treatment approach for NF1 MPNSTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 11HydroxychloroquineDrug Resistance, NeoplasmXenograft Model Antitumor AssaysNeurofibromin 1HumansAnimalsMiceNeurofibromatosis 1Nerve Sheath NeoplasmsCell Line, TumorSignal TransductionDrug Synergism

Stichwörter der Autor:innen

MPNSTNF1SHP2 inhibitionautophagyhydroxychloroquine

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11HydroxychloroquineNeurofibromin 1PTPN11 protein, humanNF1 protein, human

Autor:innen und Institutionen

  • Cancer Biology & Genetics Program, Sloan Kettering Institute, New York, NY 10065.
  • Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Laura and Isaac Perlmutter Cancer Center, Department of Medicine, New York University, New York, NY 10016.
  • Translational Medicine, AstraZeneca, Waltham, MA 02451.
  • Indiana University School of Medicine, Department of Pediatrics, Riley Hospital for Children at IU Health, Indianapolis, IN 46202.
  • Medicine, Hematology and Medical Oncology, Neurosurgery, The Mount Sinai Hospital, New York, NY 10029.

ORCID-Profile: Steven P Angus, Rebecca Brown, Xuanhua Xie, Charlene Iltis, Shelley A H Dixon, Chi Zhang, Benjamin G Neel, Luis F Parada

Förderung

  • NCI NIH HHS
  • DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP)
  • HHS | National Institutes of Health (NIH)

Zitieren

APA

Sait, S. F., Tang, K. H., Angus, S. P., Brown, R., Sun, D., Xie, X., Iltis, C., Lien, M., D Socci, N., Bale, T. A., Davis, C., Dixon, S. A. H., Zhang, C., Wade Clapp, D., Neel, B. G., & Parada, L. F. (2025). Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2407745121

Vancouver

Sait SF, Tang KH, Angus SP, Brown R, Sun D, Xie X, et al. Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2407745121

BibTeX
@article{Sait2025,
  author = {Sait, Sameer Farouk and Tang, Kwan Ho and Angus, Steven P and Brown, Rebecca and Sun, Daochun and Xie, Xuanhua and Iltis, Charlene and Lien, Michelle and D Socci, Nicholas and Bale, Tejus A and Davis, Christopher and Dixon, Shelley A H and Zhang, Chi and Wade Clapp, D and Neel, Benjamin G and Parada, Luis F},
  title = {Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2407745121}
}
Kostenlos starten →